Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
Besi Semiconductor jaardraadje 2024
Volgen
1,30 verschil hoog-laag om 16:14. Ongekend. Snel posten voordat het 1,40 en 16:15 is.
In bijlage BESI analyse van MS. Persoonlijk oneens met belangrijke aspecten van het verhaal zoals weinig moat en maar gemiddelde groei. Benieuwd naar jullie reacties...
Sectornieuws: Infineon verlaagt outlook 07-mei-2024 10:58 Koers reageert toch positief. (ABM FN-Dow Jones) Infineon heeft dinsdag de outlook voor het boekjaar 2024 verlaagd. Dit bleek dinsdag uit een kwartaalupdate van de Duitse halfgeleiderspecialist uit Neubiberg. CEO Jochen Hanebeck sprak in een toelichting van aanhoudende moeilijke marktomstandigheden. Toch vond de topman dat het afgelopen kwartaal "solide" was. Dit boekjaar zal de omzet uitkomen op ongeveer 15,1 miljard euro, voorziet Infineon. Eerder ging het bedrijf nog uit van circa 16 miljard euro. En dat was al een verlaging, want daarvoor stond de omzetoutlook op 17 miljard euro. De segmentmarge zal dit jaar niet op 20 tot 25 procent uitkomen, maar rond de 20 procent, waarschuwde de halfgeleiderspecialist dinsdag. Voor het lopende derde kwartaal rekent Infineon op een omzet van circa 3,8 miljard euro. In het afgelopen, tweede kwartaal boekte Infineon een omzet van ruim 3,6 miljard euro. Op kwartaalbasis was dit een daling van 2 procent. De koers van het aandeel Infineon steeg dinsdag met maar liefst 9,6 procent. Analisten van Citi noemden de outlookverlaging "verstandig en redelijk". Door: ABM Financial News.info@abmfn.nl Redactie: +31(0)20 26 28 999
Mooi , outlook omlaag en alles omhoog , woorden van analisten doen ertoe.
Chipie schreef op 7 mei 2024 11:33 :
Mooi , outlook omlaag en alles omhoog , woorden van analisten doen ertoe.
Je mag bij adviezen zelf kiezen. Dat voordeel heb je wel. En soms kies je gewoon niet.
tja weer naar rood. BESI gaat volledig tegen de draad in.. Het is echt over totdat er goed nieuws komt (Q2 25 juli)
Marcel H. schreef op 7 mei 2024 11:43 :
[...]
Je mag bij adviezen zelf kiezen. Dat voordeel heb je wel.
En soms kies je gewoon niet.
Fijn voor deze wijze les !
Kan iemand het volledige artikel van seeking Alpha posten, het gaat over Besi en hybrid bonding. Misschien voda? Mvg
BE Semiconductor: With A Little Delay, The Hybrid Bonding Train Is About To Leave Dutch Dividend Therapist Investment thesis BE Semiconductor Industries N.V. (OTC:BESIY) is a company that has a prominent place in my portfolio. November the 9th was the last time a wrote about the company and a lot has happened since then, BESIY has shot up to an all-time high of €182 per share. However, from March 2024 the share price is in a downward trend again and is currently around €127. Suddenly there were news items, indicating that the adoption of hybrid bonding in the memory market was being delayed. In my opinion this is just short-term noise. I am bullish about the long-term potential of BESIY, but looking at the short-term BESIY at €182 was just too much. High volatility plays an important role when it comes to BESIY and you really need to have the stomach for the stock, but there is one thing that allows me to keep my head cool, the long-term dividend growth story of the stock. This company holds a special place in my heart as this is the first company I wrote an article about on Seeking Alpha. In addition, it is one of the best performing stocks in my own portfolio as well. Despite the sharp decline, I never considered selling my position. I personally use the strategy of buying again when it is trading at an attractive price. Today I would like to update my investment thesis to assess whether the stock is worth buying at the moment, given the large drop in share price. An important note: Shares are listed on Euronext Amsterdam and the level 1 ADRs trade on the OTC markets (OTC:BESIY). I highly encourage you to buy the shares on Euronext Amsterdam for liquidity reasons. Fundamentals BESIY is without a doubt a quality business. These are the reasons to, at least, put it on your watchlist. An industry leader in a rapidly growing market BESIY is the leader in the "back-end" of the semiconductor equipment space. After a chip has been produced in the front-end, the equipment of BESIY is used to produce assemblies or packages. This segment is just a small portion of the total semiconductor market size, but it is likely to grow fast in the future. BESIY is the most dominant player in the Die Attach market, which is 77% of their total revenue. Die placement will be more and more complex in the future and it is good to see that BESIY is even more dominant in Advanced Die Placement. Their semiconductor equipment plays an important role in a more and more digital world. BESIY has an excellent position and participates in various end markets that are subject to secular growth, such as computing, automotive and mobile. BESIY has an amazing long-term track record when it comes to top-line and bottom-line growth. The company has been able to increase revenue the last four cycles. What is striking is that they are even able to increase their margins when revenue is declining. This shows that they have a healthy amount of pricing power. Compared to 2021 and 2022, their revenue is quite a bit lower, but this will probably change in 2024 and the years thereafter. Based on the research of TechInsights Assembly equipment revenue should increase rapidly in the years to come. And this is even without the inclusion of hybrid bonding, which will be an important catalyst for BESIY. This technique has the potential to become a leading one over the next decade. Hybrid bonding offers the ability to increase chips contact density and allows new chiplet architectures. In other words, an improvement in performance, cost and a reduction in energy consumption. The company itself estimates that it will be able to sell between 900 and 1,800 systems by 2030. Based on their 2022 annual report, this comes with a hefty price tag, as the company estimates a sell price between $1.5 million and $2.5 million per system. Prices for next generation products could range between $3.0 million and $8.0 million per system. These are enormous opportunities for the company in the future. Led by outstanding management Most quality companies are led by excellent managers and BESIY is no exception. The CEO Richard Blickman understands the semiconductor landscape like no other. Blickman has been working in the semiconductor industry for over 40 years and since 1995 he is the CEO of BESIY. He is also the longest-serving CEO of a Dutch listed company. Despite the fact that he regularly sells shares of the company, he still has considerable skin in the game with a total of 1.3 million shares. As described earlier in the article he has an excellent track record and it is clear that the company has been able to benefit from his knowledge and skills for years to deliver great performance every cycle. A disadvantage is the age of the CEO, so it is questionable whether his successor has as much feeling for the semiconductor landscape as Blickman. Top notch balance sheet Throughout the various cycles, the company operates from a very healthy balance sheet. Over the past 5 years, the long-term debt has always been lower than the cash, cash equivalents and deposits. This gives BESIY sufficient financial flexibility to make possible investments or acquisitions if opportunities arise. Latest quarterly earnings At first the share price dropped considerably due to BESIY's quarterly results, but a bit later the share price recovered almost completely. Looking at the table above it is clear that the weakness in demand is still there, but this was to be expected. However, the revenue of €146.3 million was still above midpoint guidance. The company is still dealing with low demand from the smartphone and automotive markets. What was also disappointing is their order intake, this was lower than expected.These were the negatives, but there were also some positives to mention. Despite disappointing demand, BESIY has still managed to achieve insanely high margins, which emphasizes their market dominance. The gross margin of 67.2% was helped by a more favorable product mix and currency benefits. There are also several signals from other companies that the automotive market is showing signs of recovery, such as Texas Instruments Incorporated (TXN). It is likely that the smartphone market will also eventually pick up again. And we are only talking about the current business activities of BESIY. What I personally think is one of the most important points from the quarterly report is that the company has increased its R&D investments in their next generation products. This is an example of confidence in the future and an indication that they are preparing for higher demand.In addition, they also increase their resource commitment to the next generation TCB systems, because they see a lot of memory related customers showing interest in the TCB assembly processes to meet future AI related capacity growth. There also seems to be a small acceleration with regard to hybrid bonding. The company expects order for 25-35 hybrid bonding systems in Q2-24 from different customers. Since these systems have a price tag of €2.5 million each This can quickly lead to an order increase of €62.5- €87.5 million in a single quarter. Combine this with an increase in demand from their current business operations and it could lead to a totally different outlook. Speaking of their Q2 outlook, the company expects that revenue will be flat, plus or minus 5%, with a gross margin between the range of 63 and 65%. So, no huge recovery yet, but things can quickly change in the next one or two quarters. At your service christo1... ;-)
Vervolg: Valuation The company is in a great position to benefit from significant growth, but on the other hand the multiples are also quite high. BESIY currently has a PE of 56 and is also significantly higher compared to its historical average. However, if earnings improve, which could also cause the PE to drop very quickly. To provide direction to the fair value, discounted cash flow analysis has been used. I will use two different scenarios to give an indication of the fair value, which is a more conservative baseline case and a more optimistic case. Based on the 2023 cash flow statement, the net cash from operating activities was €208 million minus €6 million in CapEx, which comes down to a FCF of €202 million. This is also the amount I used as a base for my calculations. Looking at the FCF from the last 10 years the growth was definitely not linear, which is normal for BESIY. The FCF growth CAGR was 10.6% on a 10Y basis, but it has to be said, this is really an unfavorable basis for comparison as BESIY may be at the bottom of the cycle at the moment. If we do the calculations from 2014 to 2021, which were both cyclical highs, it comes down to a FCF CAGR of 18.9%. When it comes to future growth a lot is about to happen in the next 5 years. There is certainly room from this level to grow their current business activities. On top of that there is the high growth expectation from the new business activities, such as hybrid bonding. It is still unclear when an acceleration in growth will take place, but I am convinced that it will happen. I am not the only one, several analysts also expect considerable revenue growth in the next 5 years. I used a 5Y growth rate of 20% for the more optimistic case, and for the 5 years thereafter 10% because it's harder to make accurate assumptions over longer periods of time. For the baseline case I used a 5Y growth rate of 15% and 10% thereafter. Since BESIY has shown in the past that its bottom-line has been able to grow much faster than its top-line, my assumptions certainly do not seem unrealistic. The average PE ratio for the company for the last five years was 33.7. Therefore, I used a terminal multiple of 30 for the more optimistic case and 25 for the baseline case. I think the high multiples are justified because of the high growth prospects and high-quality fundamentals of the business. Due to the share price volatility of BESIY, a relatively high discount rate of 12.5% was used, to adjust for the higher risk involved and it is also more of a personal hurdle rate. If we do the math, it comes down to a fair value of €129.93 per share for the optimistic case and €93.05 for the baseline case. At the moment the share price is actually below the fair value of the optimistic case. Investment risks One of the biggest investment risks at BESIY lies in the sky-high expectations. At the moment, the company has a really dominant position and it is therefore a fair question whether BESIY is able to maintain this position in the future. I hear BESIY is sometimes compared to ASML Holding N.V. (ASML) as they are both very dominant in the semiconductor equipment space. However, it is absolutely no certainty that BESIY has already won the race. It seems that BESIY has a technological advantage over its competitors, but in the back-end the entry barrier is significantly lower compared to the front-end. There is therefore a greater chance of serious competition and this can have a major impact on the investment case. Competitors such as ASM Pacific Technology (OTCPK:ASMVY), for example, are also busy with hybrid bonding and since it seems to be quite lucrative, competitors will certainly give it a try. Fortunately, the CEO is aware of this and is increasing R&D expenditure to maintain the technological lead. As the adoption of hybrid bonding lies further in the future, it may give competitors more time to join the party. It should be mentioned that BESIY has a very good track record of staying ahead of competition. In this situation, it is more than justified to work with multiple investment scenarios and applying a high discount rate. If BESIY loses its dominant position, this will have a huge impact on the top- and the bottom-line growth. As discussed in my previous article about the company, further economic headwinds, geopolitical tension and a relatively high beta are factors that need to be considered before investing in BESIY. Conclusion BESIY is a high-quality company with a cyclical nature. The company is an industry leader that is well positioned in a rapidly growing market, has great management, great capital allocation skills and has a more than healthy balance sheet. There are sufficient indications to say that the cycle is bottoming out and recovery is on its way. Their newest techniques like hybrid bonding are also gaining momentum. If you have the stomach for it and you are willing to buy and hold for at least 5 years from now on, I think it is possible to achieve excellent returns at current price levels. With this in mind I give BESIY a "BUY" rating. This doesn't mean it can't be a bumpy ride. The past has proven that BESIY's share price can easily be reduced by 50% in a short amount of time and it is certainly possible that the share price can drop to €90 or lower. Because of that, I highly recommend to use the dollar cost average principle to build up your position. In the meantime, I will let my thesis unfold while benefiting from a long-term growing dividend. Happy investing everyone! At your service christo1... ;-)
werkzaam schreef op 7 mei 2024 14:31 :
tja weer naar rood. BESI gaat volledig tegen de draad in..
Het is echt over totdat er goed nieuws komt (Q2 25 juli)
... je zag het aankomen
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)